ProKidney Corp expected to post a loss of 17 cents a share - Earnings Preview

Prokidney

08/03/2024 21:52

* ProKidney Corp  PROK.OQ   PROK.O  is expected to show no
change
in quarterly revenue when it reports  results on March 11
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for ProKidney Corp is for a
loss
of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ProKidney
Corp is
$6.00​, above​ its last closing price of $1.66. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.15       -0.16      -0.18     Missed  -14.1
 Jun. 30 2023  -0.32       -0.39      -0.14     Beat    64.4
 Mar. 31 2023  -0.25       -0.39      -0.16     Beat    59.1​
 Dec. 31 2022  -0.24       -0.25      -0.11     Beat    55.1
 ​​Sep.        -0.06       -0.24      -0.13     Beat    44.8
 30 2022                                                
                                                        ​
 This summary was machine generated March 8 at 21:51 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)